180 results on '"Ariizumi, Kiyoshi"'
Search Results
2. Melanoma-Derived Soluble DC-HIL/GPNMB Promotes Metastasis by Excluding T-Lymphocytes from the Pre-Metastatic Niches
3. Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6, Figure S7, Figure S8, Table S1, Table S2, Table S3 from DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors
4. Supplementary Figure 1 from DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T Cells
5. Supplementary Figure 2 from DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T Cells
6. Supplementary Figure 4 from DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T Cells
7. Supplementary Figure 3 from DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T Cells
8. Data from DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T Cells
9. NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
10. Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer
11. Abstract 1258: Elevated serum DC-HIL is associated with poor response to immune checkpoint inhibitors (ICI) in metastatic renal cell carcinoma (mRCC)
12. Subtractive cDNA Cloning : A New Approach to Understanding Dendritic Cell Biology
13. T Cell-Mediated Terminal Maturation of Dendritic cells
14. Sézary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-β on the cell surface
15. Establishment and Characterization of Antigen-Presenting Cell Lines (XS Series) Derived from Newborn Mouse Epidermis
16. Abstract P015: Characterization and prognostic impact of DC-HIL in advanced colorectal cancer
17. Immunoglobulin Heavy Chain Enhancer is Located Near or in an Initiation Zone of Chromosomal DNA Replication
18. T-cell-specific deletion of Mof blocks their differentiation and results in genomic instability in mice
19. The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease
20. Selective expression of vacuolar H +-ATPase subunit d2 by particular subsets of dendritic cells among leukocytes
21. Expansion of Myeloid-Derived Suppressor Cells in the Peripheral Blood and Lesional Skin of Cutaneous Lupus Patients
22. DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors
23. Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion
24. Recognition of non-self-polysaccharides by C-type lectin receptors dectin-1 and dectin-2
25. Selective expression of vacuolar H+-ATPase subunit d2 by particular subsets of dendritic cells among leukocytes
26. Identification and expression profiling of a human C-type lectin, structurally homologous to mouse dectin-2
27. Characterization of Kdap, A Protein Secreted by Keratinocytes
28. A C-type Lectin Receptor Dectin-2 is Involved in Innate Immune Recognition of Fungal Hyphae and in Upregulating IL-4 Gene Expression by Dendritic Cells
29. Genomic scale analysis of the human keratinocyte response to broad-band ultraviolet-B irradiation
30. Subtractive cDNA Cloning
31. Expression of soluble DC-HIL/gpnmb receptor in the blood of metastatic non-small cell lung carcinoma treated with anti-PD1/PDL1 monoclonal antibodies.
32. DC-HIL/Gpnmb checkpoint blockade as a synergistic combination for stereotactic ablative radiation (SAbR).
33. Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients
34. A Novel Mechanism of Glucocorticoid-induced Immune Suppression: The Inhibition of T Cell-mediated Terminal Maturation of a Murine Dendritic Cell Line
35. UVB Radiation Interrupts Cytokine-mediated Support of an Epidermal-derived Dendritic Cell Line (XS52) By a Dual Mechanism
36. 2456 Cutaneous lupus erythematosus patients have increased circulating myeloid-derived suppressor cells with immunosuppressive properties
37. Abstract 1041: Binding of soluble DC-HIL to endothelial cell creates immunosuppression on premetastatic niches
38. Abstract 3660: Blocking the DC-HIL receptor reverses the T-cell suppression induced by proliferating myeloid-derived suppressor cells in common cancer types
39. Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell–Suppressor Mechanisms
40. DC-HIL + CD14 + HLA-DR no/low Cells Are a Potential Blood Marker and Therapeutic Target for Melanoma
41. DC-HIL-Expressing Myelomonocytic Cells Are Critical Promoters of Melanoma Growth
42. The DC-HIL/Syndecan-4 Pathway Regulates Autoimmune Responses through Myeloid-Derived Suppressor Cells
43. T-cell Inhibitors
44. Inhibition of T-cell activation by syndecan-4 is mediated by CD148 through protein tyrosine phosphatase activity
45. CARD9 Mediates Dectin-2-induced IκBα Kinase Ubiquitination Leading to Activation of NF-κB in Response to Stimulation by the Hyphal Form of Candida albicans
46. DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T Cells
47. Depleting Syndecan-4+ T Lymphocytes Using Toxin-Bearing Dendritic Cell-Associated Heparan Sulfate Proteoglycan-Dependent Integrin Ligand: A New Opportunity for Treating Activated T Cell-Driven Disease
48. Binding of DC-HIL to Dermatophytic Fungi Induces Tyrosine Phosphorylation and Potentiates Antigen Presenting Cell Function
49. The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses
50. Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8 + and CD4 + T-Cell Responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.